🇺🇸 FDA
Patent

US 8110681

Compounds for the treatment of spinal muscular atrophy and other uses

granted A61PA61P13/12A61P21/00

Quick answer

US patent 8110681 (Compounds for the treatment of spinal muscular atrophy and other uses) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P13/12, A61P21/00, A61P21/02, A61P21/04